Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


06.11.2017

1 Arch Virol
2 Clin Infect Dis
1 J Gen Virol
2 J Immunol
1 J Infect
1 J Infect Dis
8 J Virol
1 Lancet Gastroenterol Hepatol
2 Lancet Infect Dis
1 Lancet Respir Med
6 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
12 PLoS One
2 Proc Natl Acad Sci U S A
3 Science
15 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. KRISHNAVAJHALA HR, Williams J, Heidner H
    An influenza A virus vaccine based on an M2e-modified alphavirus.
    Arch Virol. 2017 Oct 27. doi: 10.1007/s00705-017-3578.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. TAM YH, Valkenburg SA, Perera RAPM, Wong JHF, et al
    Immune responses to twice-annual influenza vaccination in older adults in Hong Kong.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. FATHIMA P, Blyth CC, Lehmann D, Lim FJ, et al
    The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469,589 births (1996-2012).
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Gen Virol

  4. TIAN D, Sooryanarain H, Matzinger SR, Gauger PC, et al
    Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    J Gen Virol. 2017 Nov 1. doi: 10.1099/jgv.0.000964.
    PubMed     Text format     Abstract available


    J Immunol

  5. POSTON TB, Qu Y, Girardi J, O'Connell CM, et al
    A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.
    J Immunol. 2017 Aug 30. pii: ji1700914. doi: 10.4049/jimmunol.1700914.
    PubMed     Text format     Abstract available

  6. ZAIDI I, Diallo H, Conteh S, Robbins Y, et al
    gammadelta T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations.
    J Immunol. 2017 Oct 27. pii: ji1700314. doi: 10.4049/jimmunol.1700314.
    PubMed     Text format     Abstract available


    J Infect

  7. LUCIDARME J, Lekshmi A, Parikh SR, Bray JE, et al
    Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?
    J Infect. 2017;75:95-103.
    PubMed     Text format     Abstract available


    J Infect Dis

  8. SICRE DE FONTBRUNE F, Arnaud C, Cheminant M, Boulay A, et al
    Immunogenicity and safety of yellow fever vaccine in allogeneic hematopoietic stem cell transplant recipients after withdrawal of immunosuppressive therapy.
    J Infect Dis. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  9. WANG X, Ku Z, Zhang X, Ye X, et al
    Structure, Immunogenicity and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
    J Virol. 2017 Oct 25. pii: JVI.01330-17. doi: 10.1128/JVI.01330.
    PubMed     Text format     Abstract available

  10. LIU X, Liang B, Ngwuta J, Liu X, et al
    Attenuated human parainfluenza virus type 1 (HPIV1) expressing the respiratory syncytial virus (RSV) fusion F glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of RSV F.
    J Virol. 2017 Aug 23. pii: JVI.01101-17. doi: 10.1128/JVI.01101.
    PubMed     Text format     Abstract available

  11. BROOKE CB
    Population diversity and collective interactions during influenza virus replication and evolution.
    J Virol. 2017 Aug 30. pii: JVI.01164-17. doi: 10.1128/JVI.01164.
    PubMed     Text format     Abstract available

  12. SULLIVAN JT, Sulli C, Nilo A, Yasmeen A, et al
    High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
    J Virol. 2017 Sep 6. pii: JVI.00862-17. doi: 10.1128/JVI.00862.
    PubMed     Text format     Abstract available

  13. YORK J, Nunberg JH
    Epistastic interactions within the Junin virus envelope glycoprotein complex provide an evolutionary barrier to reversion in the live-attenuated Candid#1 vaccine.
    J Virol. 2017 Oct 25. pii: JVI.01682-17. doi: 10.1128/JVI.01682.
    PubMed     Text format     Abstract available

  14. BOGDANOFF WA, Perez EI, Lopez T, Arias CF, et al
    Structural basis for the escape of human astrovirus from antibody neutralization: broad implications for rational vaccine design.
    J Virol. 2017 Oct 25. pii: JVI.01546-17. doi: 10.1128/JVI.01546.
    PubMed     Text format     Abstract available

  15. GRESETH MD, Czarnecki MW, Bluma MS, Traktman P, et al
    Isolation and Characterization of vDeltaI3 Confirms that the Vaccinia Virus SSB Plays an Essential Role in Viral Replication.
    J Virol. 2017 Nov 1. pii: JVI.01719-17. doi: 10.1128/JVI.01719.
    PubMed     Text format     Abstract available

  16. MALHERBE DC, Mendy J, Vang L, Barnette PT, et al
    Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C SHIV Mucosal Challenge.
    J Virol. 2017 Nov 1. pii: JVI.01092-17. doi: 10.1128/JVI.01092.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  17. FURLOW B
    Large hepatitis A outbreaks in USA constrain vaccine supply.
    Lancet Gastroenterol Hepatol. 2017 Oct 24. pii: S2468-1253(17)30329.
    PubMed     Text format    


    Lancet Infect Dis

  18. SRICHAROENCHAI S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, et al
    A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
    Lancet Infect Dis. 2017 Oct 20. pii: S1473-3099(17)30612.
    PubMed     Text format     Abstract available

  19. VON KONIG CHW
    Acellular pertussis vaccines: where to go to?
    Lancet Infect Dis. 2017 Oct 20. pii: S1473-3099(17)30613.
    PubMed     Text format    


    Lancet Respir Med

  20. XU C, Thompson MG, Cowling BJ
    Influenza vaccination in tropical and subtropical areas.
    Lancet Respir Med. 2017 Oct 20. pii: S2213-2600(17)30377.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  21. LEEDS M, Muscoplat MH
    Timeliness of Receipt of Early Childhood Vaccinations Among Children of Immigrants - Minnesota, 2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:1125-1129.
    PubMed     Text format     Abstract available

  22. DABBAGH A, Patel MK, Dumolard L, Gacic-Dobo M, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:1148-1153.
    PubMed     Text format     Abstract available

  23. JORBA J, Diop OM, Iber J, Henderson E, et al
    Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
    MMWR Morb Mortal Wkly Rep. 2017;66:1185-1191.
    PubMed     Text format     Abstract available

  24. MWENDA JM, Burke RM, Shaba K, Mihigo R, et al
    Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:1192-1196.
    PubMed     Text format     Abstract available

  25. HILL HA, Elam-Evans LD, Yankey D, Singleton JA, et al
    Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:1171-1177.
    PubMed     Text format     Abstract available

  26. MURTHY N, Rodgers L, Pabst L, Fiebelkorn AP, et al
    Progress in Childhood Vaccination Data in Immunization Information Systems - United States, 2013-2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:1178-1181.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  27. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
    Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Programme on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
    Pediatr Infect Dis J. 2017 Oct 28. doi: 10.1097/INF.0000000000001810.
    PubMed     Text format     Abstract available


    PLoS One

  28. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    PubMed     Text format     Abstract available

  29. ABIR T, Ogbo FA, Stevens GJ, Page AN, et al
    The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
    PLoS One. 2017;12:e0187090.
    PubMed     Text format     Abstract available

  30. DIALLO AO, Soeters HM, Yameogo I, Sawadogo G, et al
    Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    PLoS One. 2017;12:e0187466.
    PubMed     Text format     Abstract available

  31. GRANDAHL M, Larsson M, Dalianis T, Stenhammar C, et al
    Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.
    PLoS One. 2017;12:e0187193.
    PubMed     Text format     Abstract available

  32. ROSE J, Homa L, Meropol SB, Debanne SM, et al
    Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    PLoS One. 2017;12:e0187446.
    PubMed     Text format     Abstract available

  33. CAFIERO-FONSECA ET, Stawasz A, Johnson ST, Sato R, et al
    The full benefits of adult pneumococcal vaccination: A systematic review.
    PLoS One. 2017;12:e0186903.
    PubMed     Text format     Abstract available

  34. FURUKAWA K, Tanemura M, Miyoshi E, Eguchi H, et al
    A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes.
    PLoS One. 2017;12:e0184901.
    PubMed     Text format     Abstract available

  35. SASTRY M, Zhang B, Chen M, Joyce MG, et al
    Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
    PLoS One. 2017;12:e0186854.
    PubMed     Text format     Abstract available

  36. LI H, Nykoluk M, Li L, Liu LR, et al
    Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0186079.
    PubMed     Text format     Abstract available

  37. FABIANI M, Ferrante G, Minardi V, Giambi C, et al
    Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015).
    PLoS One. 2017;12:e0178122.
    PubMed     Text format     Abstract available

  38. SORIA I, Quattrocchi V, Langellotti C, Gammella M, et al
    Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.
    PLoS One. 2017;12:e0185184.
    PubMed     Text format     Abstract available

  39. CIONCADA R, Maddaluno M, Vo HTM, Woodruff M, et al
    Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    PLoS One. 2017;12:e0185843.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. BUSTAMANTE LY, Powell GT, Lin YC, Macklin MD, et al
    Synergistic malaria vaccine combinations identified by systematic antigen screening.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201702944.
    PubMed     Text format     Abstract available

  41. KOEHLER H, Cotsmire S, Langland J, Kibler KV, et al
    Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Proc Natl Acad Sci U S A. 2017;114:11506-11511.
    PubMed     Text format     Abstract available


    Science

  42. WARD JK, Colgrove J, Verger P
    France's risky vaccine mandates.
    Science. 2017;358:458-459.
    PubMed     Text format    

  43. CHAMBERLAIN AT, Lavery JV, White A, Omer SB, et al
    Ethics of maternal vaccination.
    Science. 2017;358:452-453.
    PubMed     Text format    

  44. LESLIE M
    Can flu shots help women get pregnant?
    Science. 2017;355:1247-1248.
    PubMed     Text format    


    Vaccine

  45. STREZOVA A, Godeaux O, Aggarwal N, Leroux-Roels G, et al
    A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31396.
    PubMed     Text format     Abstract available

  46. ROLFES MA, Goswami D, Sharmeen AT, Yeasmin S, et al
    Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31482.
    PubMed     Text format     Abstract available

  47. YAN J, Morrow MP, Chu JS, Racine T, et al
    Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31358.
    PubMed     Text format     Abstract available

  48. ZHONG G, Brunham RC, de la Maza LM, Darville T, et al
    National institute of allergy and infectious diseases workshop report: "Chlamydia vaccines: the way forward".
    Vaccine. 2017 Oct 30. pii: S0264-410X(17)31483.
    PubMed     Text format     Abstract available

  49. TESEMA B, Zhao JY, Jiang XP, Liu GQ, et al
    Kisspeptin recombinant oral vaccine: A master gene vaccine inhibiting the reproductive physiology and behavior of ram lambs.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31201.
    PubMed     Text format     Abstract available

  50. SHIRATSUCHI T, Rai U, Kaneko I, Zhang M, et al
    A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31474.
    PubMed     Text format     Abstract available

  51. GUSTIN MP, Ohannessian R, Giard M, Caillat-Vallet E, et al
    Use of surveillance data to calculate the sample size and the statistical power of randomized clinical trials testing Staphylococcus aureus vaccine efficacy in orthopedic surgery.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31476.
    PubMed     Text format     Abstract available

  52. STOCKWELL MS, Marchant CD, Wodi AP, Barnett ED, et al
    A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31481.
    PubMed     Text format     Abstract available

  53. PLATTEEL ACM, Henri S, Zaiss DM, Sijts AJAM, et al
    Dissecting antigen processing and presentation routes in dermal vaccination strategies.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31452.
    PubMed     Text format     Abstract available

  54. PRYSLIAK T, Maina T, Yu L, Suleman M, et al
    Induction of a balanced IgG1/IgG2 immune response to an experimental challenge with Mycoplasma bovis antigens following a vaccine composed of Emulsigen, IDR peptide1002, and poly I:C.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31445.
    PubMed     Text format     Abstract available

  55. MORIYAMA M, Takeyama H, Hasegawa H, Ichinohe T, et al
    Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31446.
    PubMed     Text format     Abstract available

  56. HARRINGTON L, Van Damme P, Vandermeulen C, Mali S, et al
    Recruitment barriers for prophylactic vaccine trials: A study in Belgium.
    Vaccine. 2017 Oct 23. pii: S0264-410X(17)31449.
    PubMed     Text format     Abstract available

  57. WOHLGEMUTH N, Ye Y, Fenstermacher KJ, Liu H, et al
    The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31414.
    PubMed     Text format     Abstract available

  58. WERA E, Mourits MCM, Hogeveen H
    Cost-effectiveness of mass dog rabies vaccination strategies to reduce human health burden in Flores Island, Indonesia.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31374.
    PubMed     Text format     Abstract available

  59. WALLACE AS, Willis F, Nwaze E, Dieng B, et al
    Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices.
    Vaccine. 2017 Oct 21. pii: S0264-410X(17)31335.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: